| Literature DB >> 1315838 |
H Claeys1, A Volckaerts, H De Beenhouwer, C Vermylen.
Abstract
An enzyme immunoassay (EIA) was developed for the determination of antibodies against the "putative" core protein of hepatitis C virus (HCV). Antigens used were recombinant fragments (amino acids 6-77 or 6-143) of the HCV core protein, produced in Escherichia coli with truncated hepatitis B core (HBc) as fusion protein. Evaluation of 385 sera positive for HCV antibodies by first generation EIA, revealed 98 (25.4%) with HCV core antibodies. HCV-RNA, determined by the polymerase chain reaction (PCR), was exclusively found in the sera positive for HCV core antibodies (89 PCR positives). In random screening of 3,708 sera, 3 sera with HCV core antibodies were found PCR positive. Only 2 of these sera were positive in the first generation EIA. It is concluded that HCV core antibody determination is a reliable test for identifying HCV carriers among blood donors.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1315838 DOI: 10.1002/jmv.1890360405
Source DB: PubMed Journal: J Med Virol ISSN: 0146-6615 Impact factor: 2.327